90 related articles for article (PubMed ID: 26084220)
61. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
62. Effect of tachycardia on lipid metabolism and expression of fatty acid transporters in heart ventricles of the rat.
Wojcik B; Harasim E; Zabielski P; Chabowski A; Gorski J
J Physiol Pharmacol; 2015 Oct; 66(5):691-9. PubMed ID: 26579575
[TBL] [Abstract][Full Text] [Related]
63. Arteriovenous Sphingosine-1-Phosphate Differences Across Selected Organs of the Rat.
Książek M; Baranowska U; Chabowski A; Baranowski M
Cell Physiol Biochem; 2018; 45(1):67-77. PubMed ID: 29316552
[TBL] [Abstract][Full Text] [Related]
64. Effect of tachycardia on mRNA andf protein expression of the principal components of the lipolytic system in the rat's heart ventricles.
Wojcik B; Miklosz A; Zabielski P; Chabowski A; Gorski J
J Physiol Pharmacol; 2017 Oct; 68(5):731-736. PubMed ID: 29375048
[TBL] [Abstract][Full Text] [Related]
65. Myocardial infarction changes sphingolipid metabolism in the uninfarcted ventricular wall of the rat.
Knapp M; Zendzian-Piotrowska M; Kurek K; Błachnio-Zabielska A
Lipids; 2012 Sep; 47(9):847-53. PubMed ID: 22833182
[TBL] [Abstract][Full Text] [Related]
66. Effect of atrial pacing on the level of bioactive sphingolipids in the heart ventricles of the rat.
Wojcik B; Baranowski M; Chabowski A; Gorski J
J Physiol Pharmacol; 2015 Jun; 66(3):385-9. PubMed ID: 26084220
[TBL] [Abstract][Full Text] [Related]
67. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
68. Chemical tools to investigate sphingolipid metabolism and functions.
Delgado A; Casas J; Llebaria A; Abad JL; Fabriás G
ChemMedChem; 2007 May; 2(5):580-606. PubMed ID: 17252619
[TBL] [Abstract][Full Text] [Related]
69. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
70. Regulation of sphingosine kinase and sphingolipid signaling.
Pitson SM
Trends Biochem Sci; 2011 Feb; 36(2):97-107. PubMed ID: 20870412
[TBL] [Abstract][Full Text] [Related]
71. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
72. Cardioprotective role of sphingosine-1-phosphate.
Knapp M
J Physiol Pharmacol; 2011 Dec; 62(6):601-7. PubMed ID: 22314562
[TBL] [Abstract][Full Text] [Related]
73. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
Ekiz HA; Baran Y
Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
[TBL] [Abstract][Full Text] [Related]
74. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development.
Duan RD; Nilsson A
Prog Lipid Res; 2009 Jan; 48(1):62-72. PubMed ID: 19027789
[TBL] [Abstract][Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
